Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
HCW Biologics Inc. - Common Stock
(NQ:
HCWB
)
1.050
-0.080 (-7.09%)
Streaming Delayed Price
Updated: 11:16 AM EST, Dec 31, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about HCW Biologics Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
Dow Falls 100 Points; Brady Posts Upbeat Results
↗
November 18, 2024
Via
Benzinga
Topics
Stocks
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
October 17, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
October 16, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
October 15, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
October 04, 2024
Via
Benzinga
HCWB Stock Earnings: HCW Biologics Reported Results for Q2 2024
↗
August 14, 2024
HCW Biologics just reported results for the second quarter of 2024.
Via
InvestorPlace
HCWB Stock Earnings: HCW Biologics Reported Results for Q1 2024
↗
May 15, 2024
HCW Biologics just reported results for the first quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Intraday Session
↗
September 30, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
April 12, 2024
Via
Benzinga
HCWB Stock Earnings: HCW Biologics Misses EPS, Misses Revenue for Q4 2023
↗
April 01, 2024
HCWB stock results show that HCW Biologics missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Why Anavex Life Sciences Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
November 27, 2023
Shares of Anavex Life Sciences Corp. (NASDAQ: AVXL) moved lower during Monday’s session after the company reported fourth-quarter financial results.
Via
Benzinga
Looking Into HCW Biologics's Return On Capital Employed
↗
March 29, 2023
Via
Benzinga
Investigator Sponsor of HCW Biologics’ Phase 1 Clinical Trial Presented Human Data Readout and Anti-Cancer Mechanism of Action of HCW9218 at 38th SITC Annual Meeting
November 08, 2023
From
HCW Biologics, Inc
Via
GlobeNewswire
Masonic Cancer Center, University of Minnesota to Present Data in Poster Presentation Human Data Readout for Phase 1 Study to Evaluate HCW9218 in Solid Tumors at SITC 38th Annual Meeting
November 01, 2023
HCW9218 is the lead product candidate of HCW Biologics Inc.
From
HCW Biologics, Inc
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
September 14, 2023
Via
Benzinga
HCW Biologics Participating at H.C. Wainwright 25th Annual Global Investment Conference in New York on September 11 – 13, 2023
September 06, 2023
Company will provide an update for clinical development and intellectual property programs, Including recent achievements and expected milestones in the next 12 months
From
HCW Biologics, Inc
Via
GlobeNewswire
Nerdy And 3 Other Stocks Under $4 Insiders Are Aggressively Buying
↗
June 08, 2023
The Dow Jones closed higher by around 90 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
$3M Bet On This Technology Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
↗
June 01, 2023
The Dow Jones closed lower by over 100 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
$25M Bet On This Consumer Cyclical Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
↗
May 25, 2023
The Dow Jones closed lower by over 250 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
Recap: HCW Biologics Q1 Earnings
↗
May 09, 2023
HCW Biologics (NASDAQ:HCWB) reported its Q1 earnings results on Tuesday, May 9, 2023 at 07:15 AM. Here's what investors need to know about the announcement. Earnings HCW Biologics reported in-line EPS...
Via
Benzinga
HCW Biologics: Q1 Earnings Insights
↗
May 09, 2023
HCW Biologics (NASDAQ:HCWB) reported its Q1 earnings results on Tuesday, May 9, 2023 at 07:15 AM. Here's what investors need to know about the announcement. Earnings HCW Biologics reported in-line EPS...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
April 27, 2023
Via
Benzinga
HCW Biologics Secures $26.25 Million Non-Dilutive Financing With Asset-Backed Development Loan
April 27, 2023
From
HCW Biologics, Inc
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
April 07, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
April 06, 2023
Via
Benzinga
Why SeaChange International Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket
↗
April 06, 2023
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
March 15, 2023
Via
Benzinga
HCW Biologics Enters CRADA with National Cancer Institute
December 08, 2022
NCI Activated as Clinical Site for Phase 1b/2 Clinical Trial to Evaluate HCW9218 in Advanced Pancreatic Cancer
From
HCW Biologics, Inc
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
September 01, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2022
↗
November 08, 2022
Upgrades
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
